Quantcast

How will new medications affect the lipoprotein apheresis situation in Germany?

Research paper by K G KG Parhofer

Indexed on: 30 Jan '13Published on: 30 Jan '13Published in: Atherosclerosis Supplements



Abstract

Regular lipid apheresis is a treatment modality for patients with severe drug resistant LDL-hypercholesterolemia or lipoprotein(a) elevation and premature atherosclerosis. A number of new approaches is currently being developed which can significantly decrease LDL-cholesterol levels alone or in combination with statins. If proven to be safe, these drugs may significantly reduce the necessity for regular lipid apheresis since more patients will achieve LDL-cholesterol treatment targets by drug therapy alone.